2
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Decreased peripheral dopaminergic activity in essential hypertension?

, , , , &
Pages 15-20 | Received 06 Apr 1982, Accepted 30 Aug 1982, Published online: 17 Mar 2010

References

  • Axelrod J. O-methylation of epinephrine and other catechols in vitro and in vivo. Science 1957; 126: 400
  • Baines A. D., Chan W. Production of urine free dopamine from DOPA; a micropuncture study. Life Sci. 1980; 26: 253
  • Caray R. M. Acute dopaminergic inhibition of aldosteron secretion is independent of angiotension II and adrenocorticotropin. J. clin. Endocr. 1982; 54: 463
  • Caray R. M., Van Loon G. R., Baines A. D., Ortt E. M. Decreased plasma and urinary dopamine during sodium depletion in man. J. clin. Endocr. 1981; 52: 903
  • Christensen N. J., Mathias C. J., Frankel H. L. Plasma and urinary dopamine: Studies of fasting and exercise in tetraplegic men. Europ. J. clin. Invest. 1976; 6: 403
  • Cuche J.-L., Kuchel O., Barbean A., Boucher R., Genest J. Relationship between adrenergic system and renin during adaptation to upright posture; a possible role for 3,4-dehydroxy-phenylethylamine (dopamine). Clin. Sci. 1972; 43: 481
  • Cuche J.-L., Kuchel O., Barbean A., Landlois Y., Boucher R., Genest J. Autonomic nervous system and benign essential hypertension in man. Circ. Res. 1974; 35: 281
  • Eide I., Kolloch R., DeQuattro V., Miano L., Dugger R., Van der Meulen J. Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension 1979; 1: 255
  • Franco-Morselli R., Elghozi L. J., Joly E., Di Giuilio S., Meyer P. Increased plasma adrenaline concentration in benign essential hypertension. Br. Med. J. 1977; 2: 1251
  • Gillis C. N., Greene N. M., Croneau L. H., Hammond G. L. Pulmonary extraction of 5-hydroxytryptamine and norepinephrine before and after cardiopulmonary bypass in man. Circ. Res. 1972; 30: 666
  • Goldstein D. S. Plasma norepinephrine during stress in essential hypertension. Hypertension 1981; 3: 551
  • Goldstein D. S. Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension 1981; 3: 48
  • Hope W., Majewski H., McCulloch M. W., Rand M. J., Story D. F. Evidence for a modulatory role of dopamine in sympathetic transmission. Circ. Res. 1980; 46: 77, (Suppl. I)
  • Hope W., McCulloch M. W., Rand M. J., Story D. F. Modulation of noradrenergic transmission in the rabbit ear artery by dopamine. Br. J. Pharmacol. 1978; 64: 527
  • Kjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P. Evidence of increased peripheral catecholamine release in patients with longstanding, untreated essential hypertension. Scand. J. clin. Lab. Invest. 1982; 42: 217
  • Kolloch R., Kobayashi K., DeQuattro V. Dopaminergic control of sympathetic tone and blood pressure: evidence in primary hypertension. Hypertension 1980; 2: 390
  • Küchel O., Buu N. T., Unger T., Lise M., Genest J. Free and conjugated plasma and urinary dopamine in human hypertension. J. clin. Endocr. 1979; 48: 425
  • Lake C. R., Gullner H. G., Polinsky R. J., Ebert M. H., Ziegler M. G., Bartter F. C. Essential hypertension: central and peripheral norepinephrine. Science 1981; 211: 955
  • Lake C. R., Ziegler M. G., Kopin I. J. Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci. 1976; 18: 1315
  • Leren P., Foss O. P., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effects of propranolol and prazocin on blood lipids. The Oslo Study. Lancet 1980; ii: 4
  • Van Loon G. R., Schwartz L., Sole M. J. Plasma dopamine responses to standing and exercise in man. Life Sci. 1979; 24: 2273
  • Nagatsu T., Rust L. A., DeQuattro V. The activity of tyrosine hydroxylase and related enzymes of catecholamine biosynthesis and metabolism in dog kidney. Effects of denervation. Biochem. Pharmacol. 1969; 18: 1441
  • Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977; 21: 625
  • Stjärne L., Brundin J. Affinity of noradrenaline and dopamine for neural α-receptors mediating negative feedback control of noradrenaline secretion in human vasoconstrictor nerves. Acta physiol. Scand. 1975; 97: 88
  • Stumpe K. O., Kolloch R., Higuchi M., Kruck F., Vetter H. Hyperprolactinemia and antihypertensive effect of bromocriptine in essential hypertension: identification of abnormal central dopamine control. Lancet 1977; ii: 211

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.